載入...
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment
Abstract Background Despite the well described heterogeneity in glioblastoma (GBM), treatment is standardized, and clinical trials investigate treatment effects at population level. Genomics-driven oncology for stratified treatments allow clinical decision making in only a small minority of screened...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley
2019-12-01
|
| 叢編: | Clinical and Translational Medicine |
| 主題: | |
| 在線閱讀: | http://link.springer.com/article/10.1186/s40169-019-0253-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|